CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF - CHALLENGER LIMITED

Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$5.92

01 Dec
2023

-0.020

OPEN

$5.91

-0.34%

HIGH

$5.97

635,119

LOW

$5.85

TARGET
$6.732 13.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . AVC . BVS . CVW . ENN . GDC . GDG . GQG . HMC . HUB . IFL . IRE . JHG . KAM . KSL . LNK . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx 42.2 50.3 xxx
DPS (cps) xxx 24.0 24.9 xxx
EPS Growth xxx 12.3% 19.4% xxx
DPS Growth xxx 4.3% 3.7% xxx
PE Ratio xxx N/A 11.8 xxx
Dividend Yield xxx N/A 4.2% xxx
Div Pay Ratio(%) xxx 56.9% 49.4% xxx

Dividend yield today if purchased 3 years ago: 4.17%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.05

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 28/08 - ex-div 12c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx42.2
DPS All xxxxxxxxxxxxxxx24.0
Sales/Revenue xxxxxxxxxxxxxxx2,229.9 M
Book Value Per Share xxxxxxxxxxxxxxx608.4
Net Operating Cash Flow xxxxxxxxxxxxxxx1,273.6 M
Net Profit Margin xxxxxxxxxxxxxxx13.25 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx7.25 %
Return on Invested Capital xxxxxxxxxxxxxxx5.28 %
Return on Assets xxxxxxxxxxxxxxx0.97 %
Return on Equity xxxxxxxxxxxxxxx7.25 %
Return on Total Capital xxxxxxxxxxxxxxx11.04 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,143.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx4,492 M
Long Term Debt xxxxxxxxxxxxxxx1,399 M
Total Debt xxxxxxxxxxxxxxx5,891 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx593 M
Price To Book Value xxxxxxxxxxxxxxx1.07

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx7.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.35 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx388 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx28,563 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.1

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

18/10/2023

5

Sell

$6.05

2.20%

While Challenger appeared surprised, says Citi, by strong shorter-duration institutional flows in the quarter underpinned by the reinvestment of a $300m mandate, the broker points out total annuity sales have declined, as compared to the same quarter last year. 

More encouragingly, much of this decline is in lower-margin, one-year fixed term sales. Combined with a decline in institutional sales, the company reported a slightly worse than anticipated net book contraction. 

The Sell rating is retained and the target price decreases to $6.05 from $6.25.

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

CGF STOCK CHART